References
- Kaplan S. A. Dosage Form Design and Bioavailability, J. Swarbrick. Lea and Febiger, Philadelphia 1973; 20
- Boardman P. L., Dudley Hart F. Ann. rheum. Dis. 1967; 26: 127
- De Haan P., Lerk C. F. Pharm. Weekbl (Sci). 1984; 6: 57
- Tanaka N., Takino S., Utsumi I. J. Pharm. Sci. 1963; 62: 664
- Das S. K., Gupta B. K. Drug Dev. Ind. Pharm. 1985; 11(No. 8), (in press)
- Pharmacopoeia of India - 1966. Ministry of Health, Govt, of India2nd edn. Manager of Publication, DelhiIndia 1970; 740
- The United States Pharmacopeia20th rev. The United States Pharmacopeial Convention, Rockville, MD 1980; 1101
- The United States Pharmacopeia20th rev. The United States Pharmacopeial Convention, Rockville, MD 1980; 400–401
- Vora M. S., Zimmer A. J., Maney P. V. J. Pharm. Sci. 1964; 52: 487
- Lang B. Pharmazie 1971; 26: 661
- Schwartz J. B., Simonelli A. P., Higuchi W. I. J. Pharm. Sci. 1968; 51: 274
- Gibaldi M., Feldman S. J. Pharm. Sci. 1967; 56: 1238
- Higuchi T. J. Pharm. Sci. 1963; 52: 1145